Project UpdateMay 13, 2026, 01:51 PM
BioHarvest Sciences Completes Stage 1 Saffron Development
AI Summary
BioHarvest Sciences Inc. announced the successful completion of Stage 1 development for a stable saffron cell bank, intended for nutraceutical and culinary applications, under its agreement with SaffronTech. This milestone validates BioHarvest's Botanical Synthesis platform and triggers the advancement to Stage 2, focusing on biomass generation for pre-commercial testing. BioHarvest retains 25% ownership of the saffron composition and will earn manufacturing royalties from future production, addressing the significant market demand for saffron while offering a sustainable supply solution.
Key Highlights
- BioHarvest Sciences completed Stage 1 development of saffron cell bank for nutraceutical and culinary applications.
- The development program with SaffronTech advances to Stage 2.
- The multi-stage development agreement is valued at $1.125 million.
- BioHarvest retains 25% ownership of the saffron composition.
- BioHarvest will earn manufacturing royalties from future saffron compound production.
- The global saffron market is estimated at nearly $500 million annually by 2025.
- The broader nutraceutical market associated with saffron's properties is estimated over $100 billion globally by 2025.
Price Impact
More from BHST